85 results
Keyword Fosfomicina EG Remove keyword
Responsible body
CAT Remove CAT filter
-
List item
Committee for Advanced Therapies (CAT) meeting with interested parties
European Medicines Agency, London, UK, 11/12/2014, Last updated: 12/05/2015risk-based approach for ATMP (Egbert Flory) PDF icon application/pdf … development, but also for e.g. GMP requirements … previous classification (e.g. in a searchable database … -
List item
Committee for Advanced Therapies (CAT) and the German Society for Transfusion Medicine and Immunohaematology (DGTI) workshop on advanced-therapy medicinal products: How to bring cell-based medicinal products successfully to the market
Dresden, Germany, 11/09/2014, Last updated: 21/10/2014advanced-therapy medicinal products (Egbert Flory) (PDF/182.25 KB … possible needs of the field e.g. for additional guidance … ATMPs – session chair: Egbert Flory CAT’s views on … -
List item
Committee for Advanced Therapies (CAT): 3-5 November 2021
European Medicines Agency, Amsterdam, the Netherlands, from 03/11/2021 to 05/11/2021, Last updated: 31/05/2022 -
List item
Committee for Advanced Therapies (CAT): 16-18 February 2022
European Medicines Agency, Amsterdam, the Netherlands, from 16/02/2022 to 18/02/2022, Last updated: 16/02/2022 -
List item
Committee for Advanced Therapies (CAT): 16-18 June 2021
European Medicines Agency, Amsterdam, the Netherlands, from 16/06/2021 to 18/06/2021, Last updated: 29/11/2021 -
List item
Committee for Advanced Therapies (CAT): 6-8 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 06/10/2021 to 08/10/2021, Last updated: 29/11/2021 -
List item
Committee for Advanced Therapies (CAT): 14-16 July 2021
European Medicines Agency, Amsterdam, the Netherlands, from 14/07/2021 to 16/07/2021, Last updated: 29/11/2021 -
List item
Committee for Advanced Therapies (CAT): 8-10 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/09/2021 to 10/09/2021, Last updated: 23/09/2021 -
List item
Committee for Advanced Therapies (CAT): 16-18 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 16/03/2022 to 18/03/2022, Last updated: 09/07/2021 -
List item
Committee for Advanced Therapies (CAT): 11-13 April 2022
European Medicines Agency, Amsterdam, the Netherlands, from 11/04/2022 to 13/04/2022, Last updated: 09/07/2021 -
List item
Committee for Advanced Therapies (CAT): 11-13 May 2022
European Medicines Agency, Amsterdam, the Netherlands, from 11/05/2022 to 13/05/2022, Last updated: 09/07/2021 -
List item
Committee for Advanced Therapies (CAT): 10-12 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 10/05/2021 to 12/05/2021, Last updated: 09/07/2021 -
List item
Committee for Advanced Therapies (CAT): 8-10 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/12/2021 to 10/12/2021, Last updated: 09/07/2021 -
List item
Committee for Advanced Therapies (CAT): 14-16 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 14/04/2021 to 16/04/2021, Last updated: 14/04/2021 -
List item
Committee for Advanced Therapies (CAT): 17-18 March 2021
European Medicines Agency, Amsterdam, the Netherlands, from 17/03/2021 to 18/03/2021, Last updated: 17/03/2021 -
List item
Committee for Advanced Therapies (CAT): 17-19 February 2021
European Medicines Agency, Amsterdam, the Netherlands, from 17/02/2021 to 19/02/2021, Last updated: 16/02/2021 -
List item
Committee for Advanced Therapies (CAT): 2-4 December 2020
Virtual meeting, from 02/12/2020 to 04/12/2020, Last updated: 21/12/2020 -
List item
Committee for Advanced Therapies (CAT): 4-6 November 2020
Virtual meeting, from 04/11/2020 to 06/11/2020, Last updated: 04/11/2020 -
List item
Expert meeting on genome editing technologies used in medicine development
European Medicines Agency, London, UK, 18/10/2017, Last updated: 01/10/2018Products (INFARMED), Portugal Egbert Flory CAT alternate, Paul-Ehrlich-Institute … -
List item
Committee for Advanced Therapies (CAT) expert meeting on scientific and regulatory considerations for adeno-associated viral vector (AVV)-based gene therapy
European Medicines Agency, London, UK, 06/09/2017, Last updated: 19/07/2018coinfection with helper virus (e.g. adenovirus). In recombinant … inclusion of specific ligands (e.g. binding to tumour receptors … due to natural exposure (e.g. up to 70 % of the population … -
List item
Committee for Advanced Therapies (CAT): 20-22 January 2021
European Medicines Agency, Amsterdam, the Netherlands, from 20/01/2021 to 22/01/2021, Last updated: 07/08/2018 -
List item
Committee for Advanced Therapies (CAT): 15-16 February 2018
European Medicines Agency, London, UK, from 15/02/2018 to 16/02/2018, Last updated: 02/05/2018 -
List item
Committee for Advanced Therapies (CAT): 14-16 March 2018
European Medicines Agency, London, UK, from 14/03/2018 to 16/03/2018, Last updated: 15/03/2018 -
List item
Multi-stakeholder advanced therapy medicinal products (ATMPs) expert meeting: exploring solutions to foster ATMPs' development and patient access in Europe
European Medicines Agency, London, UK, 27/05/2016, Last updated: 06/02/2017 -
List item
Committee for Advanced Therapies (CAT) workshop: scientific and regulatory challenges of genetically modified cell-based cancer immunotherapy products
European Medicines Agency, London, UK, from 15/11/2016 to 16/11/2016, Last updated: 08/11/2016